Training

Education

B.S. in Animal Behavior

Bucknell University
1977 - 1981

Internship in Psychiatry & Medicine​

Francis Scott Key Medical Center,
Baltimore, MD
1985-1986

Research Fellow in Neuropsychiatry

The Johns Hopkins University,
Baltimore MD
1989-1990

M.D. Degree

Medical College of Pennsylvania
1981-1985

Residency in Psychiatry​

The Johns Hopkins Hospital,
Baltimore MD
1988-1989

Board Certification

American Board of Psychiatry and Neurology, with added qualifications in Geriatric Psychiatry
October 1990

Private practice of Psychiatry

Wilmington, DE
1990 - Present

Past Medical Director of Electroconvulsive Therapy

Christiana Care Health System, Wilmington, DE 1999 - 2020

DOWNLOAD CV

Awards & Memberships

  • 1985 Alpha Omega Alpha Medical Honor Society
  • 1990 American Psychiatric Association
  • 1990 Delaware Psychiatric Society
  • 1991-1992 Golden Apple Award, for Excellence in Teaching, Delaware State Hospital Psychiatry Residency Program
  • 1994 Association for Convulsive Therapy

Hospital Administrative Appointments

  • 1/99-6/99 Medical Director, MeadowWood Behavioral Health System, New Castle, DE
  • 1993-1998 Medical Director of Adult Services, MeadowWood Behavioral Health System, New Castle, DE
  • 1993-1999 Chairman, Pharmacy & Therapeutics Committee, MeadowWood Behavioral Health System, New Castle, DE
  • 1992-1993 Chairman, Quality Improvement Committee, Department of Psychiatry, The Medical Center of Delaware, Wilmington, DE
  • 1990-1993 Director of Psychiatric Rehabilitation Consultation, The Medical Center of Delaware, Wilmington, DE

Research Experience

  • 1996-2000 Principal Investigator, HealthCore, Newark, DE
  • 1995-1996 Sub-Investigator, Clary Research Associates
  • 1989-1990 Research Fellow in Neuropsychiatry, The Johns Hopkins University—human, primate and rodent studies of mechanisms of depression following stroke
  • 1982 Fellowship, The Medical College of Pennsylvania, Department of Pharmacology—investigating the effects of environmental stress on beta-adrenergic receptor systems in rat brain

Clinical Trials Participant

Phase III Trials

  • Paroxetine vs. Imipramine vs. Placebo in Bipolar Depression, SmithKline Beecham, 1995
  • Paroxetine vs. Placebo in Generalized Social Phobia, SmithKline Beecham, 1995-1996
  • Paroxetine vs. Placebo in Long Term Treatment of Social Phobia, SmithKline Beecham, 1995-1996
  • IR Paroxetine vs. Modified Release Paroxetine in Major Depression in the Elderly, SmithKline Beecham, 1996-1997
  • Modified Release Paroxetine vs. Placebo in Panic Disorder, SmithKline Beecham, 1996-1997
  • Fixed-dose Paroxetine vs. Placebo in Generalized Social Phobia, SmithKline Beecham, 1997
  • Open Label M10907 in Schizophrenia of Other Psychotic Disorders, Hoechst Marion Roussel, 1998-1999

Phase IV Trials

  • Sertraline vs. Placebo in Elderly Outpatients with Depression, Pfizer, 1997-1998
  • Buspirone vs. Placebo in Children and Adolescents with Generalized Anxiety Disorder, Bristol-Myers Squibb, 1999

Presentations at Meetings

  • Bryer, J.B., Starkstein, S.E., Parikh, R., and Robinson, R.G.: Reduction of CSF monoamine in post-stroke depression. Paper presented at the American Psychiatric Association Convention, New York, NY, May 16, 1990
  • Yang, N.C., Leichner, P., Pearlson, G.D., Mendizabal, J., Bryer, J.B., Dhingra, U., Tien, A., and Hawkins, W: CT brain volumetrics for Alzheimer’s Disease. Paper presented by Dr. Yang at the 1998 World Congress on Medical Physics and Biomedical Engineering
  • Caudarella, M, and Bryer, J.B.: Effect of kindling and post-trial electrical stimulation on discrimination learning. Abstract presented by Dr. Caudarella at the Society for Neuroscience Convention, 1981

Lectures By Invitation

  • Effects of Alzheimer’s Disease on the Family. Presented at the Alzheimer’s Association annual conference, Wilmington DE, November 8, 1990.
  • Cognitive complications of alcohol abuse. Presented at the Department of Psychiatry Grand Rounds, The Medical Center of Delaware, November 1990.
  • False memory syndrome. Presented at Grand Rounds, MeadowWood Hospital, New Castle DE, January 1995.
  • Electroconvulsive therapy. Presented at Grand Rounds, MeadowWood Hospital, New Castle DE, March 1996.
  • Understanding bipolar disorder. MeadowWood Hospital Continuing Education Lecture Series, New Castle DE, 1993.
  • Seasonal affective disorder. . MeadowWood Hospital Continuing Education Lecture Series, New Castle DE, 1993.
  • Psychiatric complications of Alzheimer’s Disease. Presented at Leader Nursing Home, Wilmington DE, October 21, 1991
  • Bipolar Disorder. New Directions support group, Wilmington DE, 1994
  • Post-stroke depression. Stroke Club support group, Jewish Community Center, Wilmington DE, June 1996
  • Families and professionals: A partnership to recovery. Alliance for the Mentally Ill in Delaware Annual Conference, Wilmington DE, October 8, 1998
  • Non-pharmacologic treatments of depression: ECT, phototherapy, and sleep deprivation. New Directions support group, Wilmington DE, 1999.
  • Ask the doctor. Alliance for the Mentally Ill in Delaware Annual Conference, Wilmington DE, October 7, 1999
  • Numerous additional presentations at churches, hospitals, retirement communities, and to physicians

Publications

  • Bryer, J.B., Starkstein, S.E., Votypka, V., Parikh, R.M., Price, T.R., and Robinson, R.G. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. The Journal of Neuropsychiatry, Vol 4(4), 1992, pp. 440-442.
  • Bryer, J.B., Starkstein, S.E., Mayberg, H.S., and Robinson, R.G. Neuro-imaging in Secondary Affective Disorders, in P. Hauser (ed.) Brain Imaging in Affective Disorders, American Psychiatric Press, pp. 113-135.
  • Belcheva, I., Starkstein, S.E., Honig, M., Bryer, J.B., Moran, T.H., and Robinson, R.G. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens. Brain Research, Vol 533, 1991 pp. 286-291.
  • Starkstein, S.E., Bryer, J.B., Berthier, M.L., Cohen, B., Price, T.R., and Robinson, R.G. Depression after stroke: the importance of cerebral hemisphere asymmetries. The Journal of Neuropsychiatry, Vol3(3), 1991, pp. 276-285.